← Leaderboards
Gheath Al-Atrash
University Of Tx Md Anderson Can Ctr
$6,482,522
Attributed
$17,477,342
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11M · FY2017–25$20M$15M$10M$5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,477,342 · 3
By mechanism
U24$16,682,682 · 1
R21$794,660 · 2
Top collaborators
- Cara L Haymaker4 shared
- Ignacio I. Wistuba3 shared
- Steven Hsesheng Lin2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Boyi Gan$13,125,533
- Cara L Haymaker$5,881,654
- Jaffer A. Ajani$4,835,162
- Laurence E Court$2,121,512
- Juan Fueyo$8,546,462
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsInnovationResponseTumorImmunotherapyStem Cell TransplantValidationDatabasesPublishingPredictive ModelingCancer ImmunotherapyTissuesSiteCellsImmuneImmunotherapeutic AgentLinkTreatment StrategyParticipant EnrollmentCancer PatientStandard Of CareCancer TypeApplications GrantsCandidate Marker
Grant awards (8)
MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC$1,924,560
U24 · FY2025 · CA
MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC$1,828,332
U24 · FY2024 · CA
Enhancing CAR T Cell Homing Through Glycoengineering$179,870
R21 · FY2024 · CA · contact PI
MD Anderson Cancer Immune Monitoring and Analysis Center MDA-CIMAC$1,924,560
U24 · FY2023 · CA
Enhancing CAR T Cell Homing Through Glycoengineering$227,205
R21 · FY2023 · CA · contact PI
Mitigating High Grade Radiation-Induced Lymphopenia through Pretreatment Autologous Lymphocyte Infusion$176,175
R21 · FY2021 · CA
Mitigating High Grade Radiation-Induced Lymphopenia through Pretreatment Autologous Lymphocyte Infusion$211,410
R21 · FY2019 · CA
Translational Cancer Immune Monitoring and Analysis Center (TCIMAC)$11,005,230
U24 · FY2017 · CA